News & Events

See what’s new at DiFilippo Corporate Finance Group

At DCF Group, we are continually working to advance the practice of financial and tax-related valuation issues to benefit our clients. Learn about new transactions, new staff members, industry news, and upcoming events. Check back often to see the latest updates.

News

Starburst Announces $100M in Series C Financing

Starburst has raised $100M in Series C financing led by Andreessen Horowitz. Read More
News

Servier and Celsius Therapeutics Announces Target Discovery Collaboration in Colorectal Cancer

Servier and Celsius Therapeutics announced a strategic collaboration focused on the identification and validation of novel colorectal cancer (CRC) drug targets. Read More
News

Exact Sciences to Acquire Thrive Earlier Detection

Exact Sciences Corp. and Thrive Earlier Detection Corp. entered into a definitive agreement under which Exact Sciences will acquire Thrive. Read More
News

Foghorn Therapeutics Announces Pricing of Initial Public Offering

Foghorn Therapeutics announced the pricing of its initial public offering of 7.50 million shares of its common stock. Read More
News

C4 Therapeutics Raises $182 Million in Upsized IPO

C4 Therapeutics priced its upsized initial public offering at $19 per share for gross proceeds of $182.4 million. Read More
News

Oncorus Announces Pricing of Initial Public Offering

Clinical-stage biopharmaceutical company announced the pricing of its IPO of 5.8 million shares of common stock. Read More
News

Relay Therapeutics Announces Closing of Initial Public Offering

Clinical-stage precision medicine company announced the closing of its IPO of 23 million shares of its common stock. Read More
News

Generation Bio Announces Closing of Initial Public Offering

Genetic medicines company announced the closing of its initial public offering of 12,105,263 shares of common stock. Read More